Ordering Recommendation

Preferred initial screening test for G6PD deficiency. For genetic testing in individuals of African descent, refer to Glucose-6-Phosphate Dehydrogenase (G6PD) 2 Mutations (0051684); for genetic testing in individuals with other high-risk ethnic backgrounds, refer to Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) Sequencing (3004457).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Yellow (ACD solution A). Also acceptable: Green (sodium or lithium heparin), lavender (K2EDTA or K3EDTA), or pink (K2EDTA). Enzyme most stable in acid citrate dextrose (ACD).

Specimen Preparation

Do not freeze. Transport 3 mL whole blood. (Min: 1.5 mL heparin or EDTA collection tube; Min: 0.5 mL pediatric collection tube).

Storage/Transport Temperature

Refrigerated

Unacceptable Conditions

Clotted, frozen, or hemolyzed specimens.

Remarks

Pediatric minimum 0.5 mL if collected and transported in a pediatric collection K2EDTA tube. ACD collection tubes should be filled to maximum collectible volume and are not recommended for pediatric specimen collection or preservation.
ARUP G6PD results are normalized to Hemoglobin. Reporting units are U/g Hb. Alternative methods may normalize G6PD results to red blood cells and use different reporting units.

Stability

Room Temperature: 8 hours; Refrigerated: 1 week; Frozen: Unacceptable

Methodology

Quantitative Enzymatic Assay

Performed

Sun-Sat

Reported

1-3 days

Reference Interval

Test Number
Components
Reference Interval
  Glucose-6-Phosphate Dehydrogenase
Age
Reference Intervals (U/g Hb)
Less than 8 days 16.4 - 24.1
8 - 30 days 13.6 - 23.9
1 - 6 months 11.5 - 21.5
7 - 12 months 10.3 - 17.9
1 - 17 years 9.7 - 16.9
Greater than or equal to 18 years 9.6 - 16.3

Interpretive Data

World Health Organization guidance on classification of G6PD activity is as follows:
Males: G6PD activity less than 30% of the normal median are regarded as G6PD deficient. Males with G6PD activity of 30% or more of the normal median can be regarded as G6PD normal.
Females: G6PD activity less than 30% of the normal median are regarded as G6PD deficient. Females with G6PD activity of 80% or more of the normal median can be regarded as G6PD normal. G6PD activity between 30% and 80% of the normal median are regarded as intermediate activity.
Cutoffs and results are specific to this G6PD assay and configuration and cannot be used interchangeably across different assays, parameters, and/or instrument configurations.
Reference: Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure. Geneva: World Health Organization; 2018. ISBN 978-92-4-151428-6


Percent of Normal Activity (U/g Hb)
Age
100%
80%
30%
<8 days 19.7 15.8 5.9
8 - 30 days 18.2 14.6 5.5
1 - 6 months 16.1 12.9 4.8
7 - 12 months 13.8 11.0 4.1
1 - 17 years 12.9 10.3 3.9
18 years 12.7 10.2 3.8
Percentage of normal activity cutoffs to G6PD enzyme activity. 100% for males and females is defined as the 50th percentile of non-affected males.

Compliance Category

FDA

Note

Patients who have recently received transfusions have normal donor cells that may mask G-6-PD deficient erythrocytes.

Hotline History

N/A

CPT Codes

82955

Components

Component Test Code* Component Chart Name LOINC
0080135 Glucose-6-Phosphate Dehydrogenase 32546-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • G-6-PD
  • G6PD Erythrocytes
  • RBC G6PD test
Glucose-6-Phosphate Dehydrogenase